La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Winner Medical Croissance future
Future contrôle des critères 3/6
Winner Medical is forecast to grow earnings and revenue by 30.6% and 10.5% per annum respectively. EPS is expected to grow by 30.7% per annum. Return on equity is forecast to be 8.4% in 3 years.
Informations clés
30.6%
Taux de croissance des bénéfices
30.7%
Taux de croissance du BPA
| Medical Equipment croissance des bénéfices | 22.5% |
| Taux de croissance des recettes | 10.5% |
| Rendement futur des capitaux propres | 8.4% |
| Couverture par les analystes | Low |
| Dernière mise à jour | 24 Jun 2024 |
Mises à jour récentes de la croissance future
Recent updates
Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)
Aug 19
Investors Could Be Concerned With Winner Medical's (SZSE:300888) Returns On Capital
Aug 02Is Winner Medical (SZSE:300888) Using Too Much Debt?
Jul 15Winner Medical (SZSE:300888) Will Pay A Smaller Dividend Than Last Year
May 31There May Be Reason For Hope In Winner Medical's (SZSE:300888) Disappointing Earnings
May 01There Are Reasons To Feel Uneasy About Winner Medical's (SZSE:300888) Returns On Capital
Apr 26Estimating The Fair Value Of Winner Medical Co., Ltd. (SZSE:300888)
Apr 08Does Winner Medical (SZSE:300888) Have A Healthy Balance Sheet?
Mar 17There's No Escaping Winner Medical Co., Ltd.'s (SZSE:300888) Muted Earnings
Feb 28Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2026 | 10,355 | 1,178 | 923 | 1,347 | 4 |
| 12/31/2025 | 9,831 | 1,070 | 805 | 1,720 | 5 |
| 12/31/2024 | 8,815 | 920 | 2,273 | 1,366 | 5 |
| 3/31/2024 | 7,742 | 386 | 393 | 1,123 | N/A |
| 12/31/2023 | 8,185 | 580 | 310 | 1,063 | N/A |
| 9/30/2023 | 9,719 | 2,548 | 1,059 | 1,998 | N/A |
| 6/30/2023 | 10,460 | 1,440 | 1,231 | 2,341 | N/A |
| 3/31/2023 | 11,381 | 1,671 | 1,206 | 2,363 | N/A |
| 1/1/2023 | 11,351 | 1,651 | 1,784 | 2,983 | N/A |
| 9/30/2022 | 9,860 | 1,386 | 555 | 1,650 | N/A |
| 6/30/2022 | 9,135 | 1,371 | 546 | 1,475 | N/A |
| 3/31/2022 | 8,091 | 1,116 | 348 | 1,081 | N/A |
| 1/1/2022 | 8,037 | 1,239 | 128 | 872 | N/A |
| 9/30/2021 | 8,831 | 1,764 | 569 | 1,233 | N/A |
| 6/30/2021 | 12,414 | 3,539 | 1,745 | 2,492 | N/A |
| 3/31/2021 | 13,320 | 3,972 | 3,641 | 4,344 | N/A |
| 12/31/2020 | 12,534 | 3,810 | 4,194 | 4,767 | N/A |
| 9/30/2020 | 10,979 | 3,292 | 3,820 | 4,289 | N/A |
| 6/30/2020 | 6,649 | 1,349 | 2,497 | 2,828 | N/A |
| 3/31/2020 | 5,005 | 750 | 569 | 1,089 | N/A |
| 12/31/2019 | 4,575 | 546 | 153 | 600 | N/A |
| 12/31/2018 | 3,839 | 425 | -170 | 468 | N/A |
| 12/31/2017 | 3,498 | 427 | N/A | 358 | N/A |
| 12/31/2016 | 2,560 | 410 | N/A | 450 | N/A |
| 12/31/2015 | 1,819 | 221 | N/A | 269 | N/A |
| 12/31/2014 | 1,510 | 129 | N/A | 204 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: 300888's forecast earnings growth (30.6% per year) is above the savings rate (2.9%).
Bénéfices vs marché: 300888's earnings (30.6% per year) are forecast to grow faster than the CN market (21.9% per year).
Croissance élevée des bénéfices: 300888's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: 300888's revenue (10.5% per year) is forecast to grow slower than the CN market (13.4% per year).
Croissance élevée des revenus: 300888's revenue (10.5% per year) is forecast to grow slower than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: 300888's Return on Equity is forecast to be low in 3 years time (8.4%).